Dr. Bähler Bronchialpastillen neue Formel
Dr. Bähler Bronchialpastillen neue Formel is a medicine authorised by Swissmedic under authorisation number 68873. The authorisation holder is DR. BÄHLER DROPA AG. The medicinal product code is Synthetic medicines and the dispensing category is E: Supplied in any retail outlet without specialist advice, for example glucose tablets or certain care products. First authorisation was granted on 02 May 2022 and the authorisation is valid without a time limit. ATC code R05FB02 places the medicine in the group Cough and cold preparations.
| Authorisation number | 68873 |
|---|---|
| Name | Dr. Bähler Bronchialpastillen neue Formel |
| Full name | Dr. Bähler Bronchialpastillen neue Formel, Lutschpastillen |
| Authorisation holder | DR. BÄHLER DROPA AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | E · General sale |
| ATC code | R05FB02 |
| First authorisation | 02 May 2022 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Dr. Bähler Bronchialpastillen neue Formel, Lutschpastillen | E | 02 May 2022 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 40 | Tablette(n) | R05FB02 | 03.02.0. | E |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Dr. Bähler Bronchialpastillen neue Formel authorised in Switzerland?
Yes. Dr. Bähler Bronchialpastillen neue Formel is authorised by Swissmedic under authorisation number 68873, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Dr. Bähler Bronchialpastillen neue Formel have?
Dr. Bähler Bronchialpastillen neue Formel is in dispensing category E. Supplied in any retail outlet without specialist advice, for example glucose tablets or certain care products.
Who is the authorisation holder of Dr. Bähler Bronchialpastillen neue Formel?
The authorisation holder is DR. BÄHLER DROPA AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.